Research News
Dabigatran “non-inferior” to warfarin, but only just
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f1219 (Published 27 February 2013) Cite this as: BMJ 2013;346:f1219OpenUrlCrossRefPubMedWeb of Science
New oral anticoagulants offer the prospect of stability and convenience for people needing treatment for a recent deep vein thrombosis or pulmonary embolus. They might also allow longer term treatment to prevent recurrence, and Boehringer Ingelheim recently reported results from …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.